← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
March Biosciences Inc
Houston, TX
$3,124,310
Total funding
2
Grants
Funding over time
peak $2.1M · FY2024–25$2.5M$1.9M$1.3M$625K$0
'24
'25
Funding mix
By agency
NIH$3,124,310 · 2
By mechanism
R44$3,124,310 · 2
Investigators at March Biosciences Inc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
A Phase 2 multi-center trial of CD5 CAR T-cell therapy in patients with T-cell lymphoma$1,124,607
R44 · FY2025 · CA
Dual-targeting allogeneic CAR T-cells for universal therapy of T-cell malignancies$1,013,623
R44 · FY2024 · CA
Dual-targeting allogeneic CAR T-cells for universal therapy of T-cell malignancies$986,080
R44 · FY2025 · CA